Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Contrast Enhanced Ultrasound Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?#_x000D_
The contrast enhanced ultrasound market has shown robust expansion in recent years. Its value is expected to climb from $2.13 billion in 2025 to $2.26 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.7%. This historical growth can be attributed to the broader application of ultrasound imaging, a heightened demand for radiation-free diagnostic approaches, the increased availability of contrast agents, developments in cardiovascular diagnostics, and the integration of ultrasound into point-of-care settings._x000D_
_x000D_
The contrast enhanced ultrasound market size is anticipated to experience robust expansion over the coming years. It is projected to reach $2.84 billion in 2030, growing at a compound annual growth rate (CAGR) of 5.9%. This anticipated growth throughout the forecast period stems from factors such as increasing demand for real-time functional imaging, rising investments in advanced diagnostic ultrasound systems, the broadening of CEUS applications in oncology, a heightened focus on non-invasive imaging techniques, and the growing approvals of next-generation contrast agents. Key trends identified for the forecast period involve the increasing adoption of microbubble-based imaging agents, an expanding utilization of CEUS in both cardiology and oncology, the growing integration of sophisticated ultrasound software, the proliferation of portable contrast-enhanced ultrasound systems, and an enhanced emphasis on real-time perfusion imaging._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Contrast Enhanced Ultrasound Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The increasing occurrence of chronic illnesses is anticipated to drive the expansion of the contrast-enhanced ultrasound market. These are long-term medical conditions that persist over extended periods, necessitating continuous medical supervision and care. Contrast-enhanced ultrasound provides immediate, comprehensive images of various chronic ailments, such as liver cirrhosis or vascular conditions linked to hypertension, thereby contributing to more effective long-term management. For example, in June 2024, data from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a state of elevated blood sugar levels, insufficient to be classified as diabetes) in 2023, representing an 18% rise from 3,065,825 cases in 2022. Consequently, the growing prevalence of chronic diseases will fuel the growth of the contrast-enhanced ultrasound market._x000D_
_x000D_
#Contrast Enhanced Ultrasound Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The contrast enhanced ultrasound market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Equipment, Contrast Agent_x000D_
2) By Technology: Non-targeted, Targeted_x000D_
3) By Application: Hospitals, Clinics, Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Equipment: Ultrasound Machines, Portable Ultrasound Devices_x000D_
2) By Contrast Agent: Gas-filled Contrast Agents, Microbubble Contrast Agents, Lipid-based Contrast Agents_x000D_
_x000D_
#Contrast Enhanced Ultrasound Market Trends Redefining Industry Growth#_x000D_
Leading companies operating in the contrast-enhanced ultrasound market are dedicated to developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) methods, to enhance the spatial clarity of CEUS images. The integration of cutting-edge technologies within contrast-enhanced ultrasound significantly improves diagnostic capabilities, allowing healthcare professionals to gather more detailed and precise information concerning the anatomy, function, and perfusion of tissues and organs. For instance, in September 2023, Philips, a Netherlands-based entity known for developing and manufacturing medical systems and consumer electronics products, launched its Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS). This super-resolution CEUS technology employs advanced signal processing algorithms to improve the spatial resolution of CEUS images, thereby facilitating the provision of high-resolution images of blood vessels and other structures essential for diagnosing and treating a wide array of diseases, including cancer, liver disease, and vascular diseases._x000D_
_x000D_
#Contrast Enhanced Ultrasound Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the contrast enhanced ultrasound market are General Electric Company, Bayer AG, Siemens Healthcare GmbH, Koninklijke Philips N.V., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Samsung Healthcare, Alpinion Medical Systems, Acusphere Inc., Solstice Pharmaceuticals B.V. _x000D_
_x000D_
#View The Full Contrast Enhanced Ultrasound Market Report:#_x000D_
_x000D_
#Contrast Enhanced Ultrasound Market Geographic Distribution And Regional Opportunities#_x000D_
North America was the largest region in the contrast-enhanced ultrasound market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contrast enhanced ultrasound market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.